Home › Cancro della vescica › California › San Francisco
Studi clinici su Cancro della vescica a San Francisco, CA
13 studi su Cancro della vescica cercano partecipanti presso sedi a San Francisco e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
In reclutamentoFase 1/2
- UCSF Medical Center at Mission Bay ( Site 5044), San Francisco
Imaging Study of [89Zr]DFO-YS5 for Cancer Detection
In reclutamentoFase 1
- University of California, San Francisco, San Francisco
Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer
In reclutamentoFase 1/2
- University of California, San Francisco, San Francisco
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
In reclutamentoFase 3
- UCSF Medical Center at Mission Bay, San Francisco
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
In reclutamentoFase 1
- UCSF Medical center Parnassus, San Francisco
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
In reclutamentoFase 2/3
- Pacific Hematology Oncology Associates, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
In reclutamentoFase 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
In reclutamentoFase 3
- Research Site, San Francisco
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
In reclutamentoFase 2
- UCSF Cancer Center MZ Phlebotomy, San Francisco
- UCSF Mount Zion Phlebotomy, San Francisco
- UCSF Parnassus Phlebotomy, San Francisco
- e altri 3
Predicting BCG Response
In reclutamentoStudio osservazionale
- UCSF, San Francisco
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
In reclutamentoFase 1
- University of California San Francisco, San Francisco
Blue Light Cystoscopy With Cysview® Registry
In reclutamentoStudio osservazionale
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, San Francisco
Studi su Cancro della vescica in altre città
- New York City, NY35 studi
- Nashville, TN31 studi
- Houston, TX31 studi
- Dallas, TX27 studi
- Boston, MA26 studi
- Washington, DC26 studi
- Los Angeles, CA24 studi
- Baltimore, MD24 studi
- St. Louis, MO22 studi
- Philadelphia, PA21 studi
- Seattle, WA21 studi
- Edison, NJ21 studi
Altri studi a San Francisco
- Cancro alla prostata45 studi
- Cancro al seno43 studi
- Cancro del polmone non a piccole cellule36 studi
- Cancro (tutti i tipi)35 studi
- Insufficienza cardiaca29 studi
- Cancro metastatico28 studi
- Cancro ai polmoni23 studi
- Melanoma22 studi
- Cancro pancreatico20 studi
- Cancro ovarico19 studi
- Cancro colorettale18 studi
- Malattie cardiovascolari18 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.